Sinus drug delivery startup Intersect ENT files for $80 million IPO

Drug delivery technology developer Intersect ENT filed plans on Monday to raise up to $80 million in an IPO...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.